Top

Published in:

01-03-2022 | Review

Nanotechnology and COVID-19: quo vadis?

Authors: João Lima Tavares, Iago Dillion Lima Cavalcanti, Nereide Stela Santos Magalhães, Mariane Cajubá de Britto Lira Nogueira

Published in: Journal of Nanoparticle Research | Issue 3/2022

Activate our intelligent search to find suitable subject content or patents.

search-config

AI-assisted search

Off

Abstract

The pandemic COVID-19 has worried everyone due to the high mortality rate and the high number of people hospitalized with severe acute respiratory syndrome caused by SARS-CoV-2. Given the seriousness of this disease, several companies and research institutions have sought alternative treatment and/or prevention methods for COVID-19. Due to its versatility, nanotechnology has allowed the development of protective equipment and vaccines to prevent the disease and reduce the number of severe COVID-19 cases. Thus, this article combined the main works and products developed in a nanotechnological field for COVID-19. We performed a literature search using the keywords “COVID-19,” “SARS-CoV-2,” “nanoparticles,” “nanotechnology,” and “liposomes” in the SciELO, Scifinder, PubMed, Sciencedirect, ClinicalTrials, and Nanotechnology Products databases Database. The data survey indicated 48 articles, 62 products, and 32 patents. The use of nanotechnology against COVID-19 has brought benefits in several parameters of this disease, helping develop rapid diagnostic tests that release the result in 10 min, as well as developing vaccines containing genetic material from SARS-CoV-2 (DNA, mRNA, and protein subunits). Nanotechnology is an exceptional ally against COVID-19, contributing to the most diverse areas, helping both prevent, diagnose, and treat COVID-19.

previous article Oxygen vacancies in nanostructured hetero-interfacial oxides: a review

next article Applications of nanodiamonds in the diagnosis and treatment of neurological diseases

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

inform now

Almeida DS, Martins LD, Muniz EC, Rudke AP, Squizzato R, Beal A et al (2020) Biodegradable CA/CPB electrospun nanofibers for efficient retention of airborne nanoparticles. Process Saf Environ Prot 144:177–185. https://doi.org/10.1016/j.psep.2020.07.024CrossRef

Anselmo AC, Mitragotri S (2019) Nanoparticles in the clinic: an update. Bioengineering & Translational Medicine 4(3):e10143. https://doi.org/10.1002/btm2.10143CrossRef

Bhat EA, Khan J, Sajjad N, Ali A, Aldakeel FM, Mateen A et al (2021) SARS-CoV-2: insight in genome structure, pathogenesis and viral receptor binding analysis – an updated review. Int Immunopharmacol 95:107493. https://doi.org/10.1016/j.intimp.2021.107493CrossRef

Bobo D, Robinson KJ, Islam J, Thurecht KJ, Corrie SR (2016) Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date. Pharm Res 33(10):2373–2387. https://doi.org/10.1007/s11095-016-1958-5CrossRef

Callaway E, Mallapaty S (2021) Novavax offers first evidence that COVID vaccines protect people against variants. Nature. Available in: https://www.nature.com/articles/d41586-021-00268-9. Accessed in: May 12, 2021

Caster JM, Patel AN, Zhang T, Wang A (2016) Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 9(1):e1416. https://doi.org/10.1002/wnan.1416CrossRef

Cavalcanti IDL, Nogueira MCBL (2020) Pharmaceutical nanotechnology: which products are been designed against COVID-19? J Nanoparticle Res 22(276). https://doi.org/10.1007/s11051-020-05010-6

Cavalcanti IDL, Medeiros SMFRS, Macêdo DCS, Cavalcanti IMF, Nogueira MCBL (2020) Nanocarriers in the delivery of hydroxychloroquine to the respiratory system: an alternative to COVID-19. Current Drug Delivery 17 https://doi.org/10.2174/1567201817666200827110445

Chan WCW (2020) Nano research for COVID-19. ACS Nano. https://doi.org/10.1021/acsnano.0c02540CrossRef

Chauhan G, Madou MJ, Kalra S, Chopra V, Ghosh D, Martinez-Chapa SO (2020) Nanotechnology for COVID-19: therapeutics and vaccine research. ACS Nano 17:7760–7782. https://doi.org/10.1021/acsnano.0c04006CrossRef

Cheng R, Ou S (2019) Nanocomposite-based graphene for nanosensor applications. Intechopen. London, United Kingdom

Choudhary J, Dheeman S, Sharma V, Katiyar P, Karn SK, Sarangi MK et al (2021) Insights of severe acute respiratory syndrome coronavirus (SARS-CoV-2) pandemic: a current review. Biological Procedures Online 23(5). https://doi.org/10.1186/s12575-020-00141-5

Dai L, Gao GF (2021) Viral targets for vaccines against COVID-19. Nat Rev Immunol 21:73–82. https://doi.org/10.1038/s41577-020-00480-0CrossRef

Dejnirattisai W, Zhou D, Supasa P, Liu C, Mentzer AJ, Ginn HM et al (2021) Antibody evasion by the P.1 strain of SARS-CoV-2. Cell 184(11):2939–2954. https://doi.org/10.1016/j.cell.2021.03.055CrossRef

Douafer H, Andrieu V, Brunel JM (2020) Scope and limitations on aerosol drug delivery for the treatment of infectious respiratory diseases. J Control Release 325:276–292. https://doi.org/10.1016/j.jconrel.2020.07.002CrossRef

Draz MS, Shafiee H (2018) Applications of gold nanoparticles in virus detection. Theranostics 8(7):1985–2017. https://doi.org/10.7150/thno.23856CrossRef

Fan FR, Tian ZQ, Wang ZL (2012) Flexible triboelectric generator. Nano Energy 1(2):328–334. https://doi.org/10.1016/j.nanoen.2012.01.004CrossRef

Farjadian F, Ghasemi A, Gohari O, Roointan A, Karimi M, Hamblin MR (2019) Nanopharmaceutical and nanomedicines currently on the market: challenges and opportunities. Nanomedicine (london) 14(1):93–126. https://doi.org/10.2217/nnm-2018-0120CrossRef

FDA – U.S. Food & Drug Administration (2020) Search for FDA guidance documents [Internet]. FDA. Available from: http://www.fda.gov/regulatory-information/search-fda-guidance-documents. Accessed in: June 6, 2021.

Forni G, Mantovani A (2021) COVID-19 vaccines: where we stand and challenges ahead. Cell Death Differ 28:626–639. https://doi.org/10.1038/s41418-020-00720-9CrossRef

Galdiero M, Galdiero M, Folliero V, Zannella C, Filippis A, Mali A et al (2021) SARS-CoV-2 vaccine development: where are we? Eur Rev Med Pharmacol Sci 25:2752–2784

Germain M, Caputo F, Metcalfe S, Tosi G, Spring K, Aslund AKO et al (2020) Delivering the power of nanomedicine to patients today. J Control Release 326:164–171. https://doi.org/10.1016/j.jconrel.2020.07.007CrossRef

Gupta R, Sagar P, Priyadarshi N, Kaul S, Sandhir R, Rishi V, Singhal NK (2020) Nanotechnology-based approaches for the detection of SARS-CoV-2. Frontiers in Nanotechnology 2:589832. https://doi.org/10.3389/fnano.2020.589832CrossRef

Han HJ, Nwagwu C, Anyim O, Ekweremadu C, Kim S (2021) COVID-19 and cancer: from basic mechanisms to vaccine development using nanotechnology. International Immunopharmacology 90 https://doi.org/10.1016/j.intimp.2020.107247

Hashemi SA, Golab Behbahan NG, Bahrani S, Mousavi SM, Gholami A, Ramakrishna S et al (2021) Ultra-sensitive viral glycoprotein detection NanoSystem toward accurate tracing SARS-CoV-2 in biological/non-biological media. Biosens Bioelectron 171:112731. https://doi.org/10.1016/j.bios.2020.112731CrossRef

Huang L, Ding L, Zhou J, Chen S, Chen F, Zhao C et al (2021) One-step rapid quantification of SARS-CoV-2 virus particles via low-cost nanoplasmonic sensors in generic microplate reader and point-of-care device. Biosens Bioelectron 171:112685. https://doi.org/10.1016/j.bios.2020.112685CrossRef

Kabir ER, Mustafa N, Nausheen N, Sharif Siam MK, Syed EU (2021) Exploring existing drugs: proposing potential compounds in the treatment of COVID-19. Heliyon 7(2):e06284. https://doi.org/10.1016/j.heliyon.2021.e06284CrossRef

Kanno AI, Barbosa MMF, Moraes L, Leite LCC (2021) SARS-CoV-2 vaccine development and how Brazil is contributing. Genet Mol Biol 44(1):1–15. https://doi.org/10.1590/1678-4685-gmb-2020-0320CrossRef

Keech C, Albert G, Cho I, Robertson A, Reed P, Neal S et al (2020) Phase 1–2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine. N Engl J Med 383:2320–2332. https://doi.org/10.1056/NEJMoa2026920CrossRef

Khurana A, Allawadhi P, Khurana I, Allwadhi S, Weiskirchen R, Banothu AK et al (2021) Role of nanotechnology behind the success of mRNA vaccines for COVID-19. Nanotoday 38(101142) https://doi.org/10.1016/j.nantod.2021.101142

Kostarelos K (2020) Nanoscale nights of COVID-19. Nat Nanotechnol 15(5):343–344. https://doi.org/10.1038/s41565-020-0687-4CrossRef

Kumar AU, Kadiresen K, Gan WC, Ling APK (2021) Current updates and research on plant-based vaccines for coronavirus disease 2019. Clinical and Experimental Vaccine Research 10(1):13–23. https://doi.org/10.7774/cevr.2021.10.1.13CrossRef

Kyriakidis NC, López-Cortés A, González EV, Grimaldos AB, Prado EO (2021) SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates. npj Vaccines 6(28). https://doi.org/10.1038/s41541-021-00292-w.

Lee J, Kim J (2020) Material properties influencing the charge decay of electret filters and their impact on filtration performance. Polymers 12(3):721. https://doi.org/10.3390/polym12030721CrossRef

Leung WWF, Sun Q (2020) Electrostatic charged nanofiber filter for filtering airborne novel coronavirus (COVID-19) and nano-aerosols. Separation and Purification Technology 116886 https://doi.org/10.1016/j.seppur.2020.116886

Liu D, Ju C, Han C, Shi R, Chen X, Duan D et al (2020a) Nanozyme chemiluminescence paper test for rapid and sensitive detection of SARS-CoV-2 antigen. Biosens Bioelectron 173:112817. https://doi.org/10.1016/j.bios.2020.112817CrossRef

Liu C, Zhou Q, Li Y, Garner LV, Watkins SP, Carter LJ et al (2020b) Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases. ACS Cent Sci 6(3):315–331. https://doi.org/10.1021/acscentsci.0c00272CrossRef

Mehra MR, Desai SS, Ruschitzka F, Patel AN (2020) Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet 395(10240):1820. https://doi.org/10.1016/S0140-6736(20)31180-6CrossRef

Mehta M, Prasher P, Sharma M, Shastri MD, Khurana N, Vyas M et al (2020) Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): a hypothesis. Medical Hypotheses 144. https://doi.org/10.1016/j.mehy.2020.110254.

Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E (2020) A novel coronavirus emerging in China — key questions for impact assessment. N Engl J Med 382(8):692–694. https://doi.org/10.1056/NEJMp2000929CrossRef

NanoBio® Protect Nasal Antiseptic Solution (2020) Available in: https://www.nanobioprotect.com. Accessed in: June 6, 2021

Nanomatrix materials (2021) Available in: https://www.nmmaterials.com. Accessed in: June 6, 2021

Nanotechnology Products Database (2020.) COVID-19 Available in: https://product.statnano.com/. Accessed in: June 6, 2021

Nel AE, Miller JF (2021) Nano-enabled COVID-19 vaccines: meeting the challenges of durable antibody plus cellular immunity and immune escape. ACS Nano. https://doi.org/10.1021/acsnano.1c01845CrossRef

Nooraei S, Bahrulolum H, Hoseini ZS, Katalani C, Hajizade A, Easton AJ et al (2021) Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers. Journal of Nanobiotechnology 19(59) https://doi.org/10.1186/s12951-021-00806-7

Novochizol (2020) Aerosol formulation of COVID-19. Available in: https://www.novochizol.ch/. Accessed in: June 6, 2021

Palmieri V, De Maio F, De Spirito M, Papi M (2021) Face masks and nanotechnology: keep the blue side up. Nano Today 37:101077. https://doi.org/10.1016/j.nantod.2021.101077CrossRef

Patented anti-microbial NanoDiamonds (ND) mask. 2020. Available in: https://www.master-dynamic.com. Accessed in: June 6, 2021

Pati R, Shevtsov M, Sonawane A (2018) Nanoparticle vaccines against infectious diseases. Frontiers in Immunology 9(2224). https://doi.org/10.3389/fimmu.2018.02224.

Pindiprolu SKSS, Kumar CSP, Kumar Golla VS, P. L, K. SC, S.K. EB, et al (2020) Pulmonary delivery of nanostructured lipid carriers for effective repurposing of salinomycin as an antiviral agent. Medical Hypotheses 143:109858 https://doi.org/10.1016/j.mehy.2020.109858

Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S et al (2020) Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383:2603–2615. https://doi.org/10.1056/NEJMoa2034577CrossRef

Poole CP, Owens FJ (2010) Introduction to nanotechnology. New Delhi: Wiley India

Powell AE, Zhang K, Sanyal M, Tang S, Weidenbacher PA, Li S et al (2020) A single immunization with spike-functionalized ferritin vaccines elicits neutralizing antibody responses against SARS-CoV-2 in mice. BioRxiv. https://doi.org/10.1101/2020.08.28.272518CrossRef

Rao VK (2021) Point of care diagnostic devices for rapid detection of novel coronavirus (SARS-nCoV19) pandemic: a review. Frontiers in Nanotechnology 2:593619. https://doi.org/10.3389/fnano.2020.593619CrossRef

Refaat H, Mady FM, Sarhan HA, Rateb HS, Alaaeldin E (2021) Optimization and evaluation of propolis liposomes as a promising therapeutic approach for COVID-19. Int J Pharm 592:120028. https://doi.org/10.1016/j.ijpharm.2020.120028CrossRef

Reinholz J, Landfester K, Mailänder V (2018) The challenges of oral drug delivery via nanocarriers. Drug Delivery 25(1):1694–1705. https://doi.org/10.1080/10717544.2018.1501119CrossRef

Sahin U, Muik A, Derhovanessian E, Vogler I, Kranz LM, Vormehr M et al (2020) COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. Nature 586:594–599. https://doi.org/10.1038/s41586-020-2814-7CrossRef

Saunders KO, Lee E, Parks R, Martinez DR, Li D, Chen H et al (2021) Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses. Nature. https://doi.org/10.1038/s41586-021-03594-0CrossRef

Shih H-I, Wu C-J, Tu Y-F, Chi C-Y (2020) Fighting COVID-19: a quick review of diagnoses, therapies, and vaccines. Biomedical Journal 43(4):341–354. https://doi.org/10.1016/j.bj.2020.05.021CrossRef

Shin MD, Shukla S, Chung YH, Beiss V, Chan SK, Ortega-Rivera OA et al (2020) COVID-19 vaccine development and a potential nanomaterial path forward. Nat Nanotechnol 15:646–655. https://doi.org/10.1038/s41565-020-0737-yCrossRef

Simone-Finstrom M, Spivak M (2010) Propolis and bee health: the natural history and significance of resin use by honey bees. Apidologie 41(3):295–311. https://doi.org/10.1051/apido/2010016CrossRef

The Lancet Microbe (2021) COVID-19 vaccines: the pandemic will not end overnight. The Lancet Microbe Editorial 2(1):e1. https://doi.org/10.1016/S2666-5247(20)30226-3CrossRef

Udugama B, Kadhiresan P, Kozlowski HN, Malekjahani A, Osborne M, Li VYC et al (2020) Diagnosing COVID-19: the disease and tools for detection. ACS Nano 14(4). https://doi.org/10.1021/acsnano.0c02624.

Uzunian A (2020) Coronavirus SARS-CoV-2 and Covid-19. Jornal Brasileiro De Patologia e Medicina Laboratorial 56:1–4. https://doi.org/10.5935/1676-2444.20200053CrossRef

Valizadeh H, Abdolmohammadi-vahid S, Danshina S, Ziya Gencer M, Ammari A, Sadeghi A et al (2020) Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients. Int Immunopharmacol 89:107088. https://doi.org/10.1016/j.intimp.2020.107088CrossRef

Vasir J, Reddy M, Labhasetwar V (2005) Nanosystems in drug targeting: opportunities and challenges. Curr Nanosci 1(1):47–64. https://doi.org/10.2174/1573413052953110CrossRef

Walls AC, Fiala B, Schafer A, Wrenn S, Pharm MN, Murphy M et al (2020) Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2. Cell 183(5):1367–1382. https://doi.org/10.1016/j.cell.2020.10.043CrossRef

Walsh EE, Frenck R, Falsey AR, Kitchin N, Absalon J, Gurtman A et al (2020a) RNA-based COVID-19 vaccine BNT162b2 selected for a pivotal efficacy study. N Engl J Med. https://doi.org/10.1056/NEJMoa2027906CrossRef

Walsh EE, Frenck RW, Falsey AR, Kitchin N, Absalon J, Gurtman A et al (2020b) Safety and immunogenicity of two RNA-based covid-19 vaccine candidates. N Engl J Med 383(25):2439–2450. https://doi.org/10.1056/NEJMoa2027906CrossRef

Wang X, Sun W, Yang W, Gao S, Sun C, Li Q (2019) Mesoporous silica-protected silver nanoparticle disinfectant with controlled Ag+ ion release, efficient magnetic separation, and effective antibacterial activity. Nanoscale Advances 1(2):840–848. https://doi.org/10.1039/C8NA00275DCrossRef

WHO (2020b) World Health Organization. Coronavirus disease 2019 (cOVID-19) situation report - 84. Available in: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Access in: July 7, 2021.

Wise J (2021) Covid-19: is vaccination roll out reducing cases and deaths in the UK? The BMJ 372(506). https://doi.org/10.1136/bmj.n506

Wu C, Wang AC, Ding W, Guo H, Wang ZL (2018) Triboelectric nanogenerator: a foundation of the energy for the new era. Adv Energy Mater 9(1):1802906. https://doi.org/10.1002/aenm.201802906CrossRef

Yan ZP, Yang M, Lai CL (2021) COVID-19 vaccines: a review of the safety and efficacy of current clinical trials. Pharmaceuticals 14(406). https://doi.org/10.3390/ph14050406.

Yang D (2021) Application of nanotechnology in the COVID-19 pandemic. Int J Nanomed 16:623–649. https://doi.org/10.2147/IJN.S296383CrossRef

Zhang Y, Zhang H, Wang X, Wang J, Zhang X, Zhang Q (2012) The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles. Biomaterials 33(2):679–691. https://doi.org/10.1016/j.biomaterials.2011.09.072CrossRef

Zhang Q, Honko A, Zhou J, Gong H, Downs SN, Vasquez JH et al (2020a) Cellular nanosponges inhibit SARS-CoV-2 infectivity. Nano Lett 20(7):5570–5574. https://doi.org/10.1021/acs.nanolett.0c02278CrossRef

Zhang NN, Li XF, Deng YQ, Zhao H, Huang YJ, Yang G et al (2020b) A thermostable mRNA vaccine against COVID-19. Cell 182(5):1271–1283. https://doi.org/10.1016/j.cell.2020.07.024CrossRef

Zhang R, Hristovski D, Schutte D, Kastrin A, Fiszman M, Kilicoglu H (2021a) Drug repurposing for COVID-19 via knowledge graph completion. J Biomed Inform 115:103696. https://doi.org/10.1016/j.jbi.2021.103696CrossRef

Zhang R, Xu Q, Bai S, Hai J, Cheng L, Xu G et al (2021b) Enhancing the filtration efficiency and wearing time of disposable surgical masks using TENG technology. Nano Energy 79:105434. https://doi.org/10.1016/j.nanoen.2020.105434CrossRef

Title: Nanotechnology and COVID-19: quo vadis?
Authors: João Lima Tavares
Iago Dillion Lima Cavalcanti
Nereide Stela Santos Magalhães
Mariane Cajubá de Britto Lira Nogueira
Publication date: 01-03-2022
Publisher: Springer Netherlands
Published in: Journal of Nanoparticle Research / Issue 3/2022
Print ISSN: 1388-0764
Electronic ISSN: 1572-896X
DOI: https://doi.org/10.1007/s11051-022-05452-0

Springer Professional

Abstract

Please log in to get access to your license.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Springer Professional "Technik"

Other articles of this Issue 3/2022

Cluster modeling of nanostructurization-driven reamorphization pathways in glassy arsenoselenides: a case study of arsenic monoselenide g-AsSe

Improvement of hydrogen production performance by in situ doping of carbon nanotubes into TiO2 materials

Preparation and release properties of pH-sensitive mesoporous silica composite nanocarriers

Retraction Note to: Modeling and design of Magnetic Tunneling Junction using MoS2/graphene quantum dots/MoS2 approach

Paper-based colorimetric sensor for detection of chloride anions in water using an epoxy-silver nanocomposite

Macro-prepared Cs4PbBr6/CsPbBr3 perovskite screen printing inks

Premium Partners